(732) 390-7750
Contact Us
Payments
Patient Portal
Make A Referral
Start typing & press "Enter" or "ESC" to close
Appointments
Locations
Care Team
For Patients
Patient Care Information
Medical Oncology
Radiation Oncology
The Science of Treatment
Deep Inspiration Breath Hold (DIBH)
Leading-Edge HDR & LDR Brachytherapy
SpaceOAR Hydrogel
Intensity Modulated Radiation Therapy (IMRT)
Accelerated Partial Breast Irradiation (APBI)
Prone Breast Radiation Therapy
Prostate Seed Implantation
Proton Therapy
Skin Cancer Treatment
Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery
Theranostics
TomoTherapy
Breast Care
Hematology
Osteoarthritis/Radiation
Palliative & Supportive Care
Social Work
Infusion
Pharmacy
Nutrition
Diagnoses
FAQ & Resources
Before Your First Visit
New Patients
Patient Stories
Awards/Recognition
Support Groups
Upcoming Programs
Past Programs
Magazine
Billing & Insurance
Financial Advocacy
Tobacco Cessation
Transportation Resources
FAQ
Online Resources
Dignicap
Research
Clinical Trials
Research News
About
Blogs
About Us
Our Care Team
Our Leadership
News & Events
Careers
ASHORE Program
MajesTEC-7 - A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma
Go To Trial Homepage
